[
  {
    "ts": null,
    "headline": "NEW YORK MARKET CLOSE: Shares decline as Trump doubles down on Powell",
    "summary": "NEW YORK MARKET CLOSE: Shares decline as Trump doubles down on Powell",
    "url": "https://finnhub.io/api/news?id=b546be252283fd42e650e5fee307ba7a6183e7b940455a3232fcbbc074728104",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745268258,
      "headline": "NEW YORK MARKET CLOSE: Shares decline as Trump doubles down on Powell",
      "id": 134027292,
      "image": "",
      "related": "JNJ",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=b546be252283fd42e650e5fee307ba7a6183e7b940455a3232fcbbc074728104"
    }
  },
  {
    "ts": null,
    "headline": "Intuitive Surgical: Great Company, Wrong Price",
    "summary": "Intuitive Surgical: Great Company, Wrong Price",
    "url": "https://finnhub.io/api/news?id=917eb409627a4ae8d3612eeff6089d4df60fdb2070e1c02f6497c5511b3d6e1d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745248871,
      "headline": "Intuitive Surgical: Great Company, Wrong Price",
      "id": 134025657,
      "image": "",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=917eb409627a4ae8d3612eeff6089d4df60fdb2070e1c02f6497c5511b3d6e1d"
    }
  },
  {
    "ts": null,
    "headline": "Is Johnson & Johnson (JNJ) the Best American Dividend Stock to Buy According to Analysts?",
    "summary": "We recently published a list of the 13 Best American Dividend Stocks to Buy According to Analysts. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best American dividend stocks. Dividend-paying stocks have long benefited investors by delivering consistent and solid returns. During periods of economic […]",
    "url": "https://finnhub.io/api/news?id=3659c90f63d32b4250322d091bc105802065c4b995d211813cc7eb247275f9da",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745245378,
      "headline": "Is Johnson & Johnson (JNJ) the Best American Dividend Stock to Buy According to Analysts?",
      "id": 134022762,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "We recently published a list of the 13 Best American Dividend Stocks to Buy According to Analysts. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best American dividend stocks. Dividend-paying stocks have long benefited investors by delivering consistent and solid returns. During periods of economic […]",
      "url": "https://finnhub.io/api/news?id=3659c90f63d32b4250322d091bc105802065c4b995d211813cc7eb247275f9da"
    }
  },
  {
    "ts": null,
    "headline": "How To Build A $500,000 Dividend Portfolio That Could Yield 18.35% In 20 Years",
    "summary": "How To Build A $500,000 Dividend Portfolio That Could Yield 18.35% In 20 Years",
    "url": "https://finnhub.io/api/news?id=8e6e3fa32e40da513514f0f565d1f27638b2825a954a29a44461dbeec46ac129",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745244000,
      "headline": "How To Build A $500,000 Dividend Portfolio That Could Yield 18.35% In 20 Years",
      "id": 134025125,
      "image": "",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=8e6e3fa32e40da513514f0f565d1f27638b2825a954a29a44461dbeec46ac129"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson unveils highly anticipated and potential practice-changing data in bladder cancer treatment at AUA",
    "summary": "Johnson & Johnson (NYSE: JNJ) announced today that new data from its leading oncology pipeline will be presented at the American Urological Association (AUA) 2025 Annual Meeting, taking place April 26-29 in Las Vegas. Among the highlights are the 12-month duration of response (DOR) data from the Phase 2b Cohort 2 SunRISe-1 study, evaluating TAR-200—an intravesical gemcitabine releasing system—for patients with Bacillus Calmette-Guérin (BCG)—unresponsive, high-risk non-muscle-invasive bladder can",
    "url": "https://finnhub.io/api/news?id=e353c94c4c3dfe5cdfb5393e8e1eb40bd0bd27efffa1ddbc5cc82573235c19d3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745242560,
      "headline": "Johnson & Johnson unveils highly anticipated and potential practice-changing data in bladder cancer treatment at AUA",
      "id": 134022763,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE: JNJ) announced today that new data from its leading oncology pipeline will be presented at the American Urological Association (AUA) 2025 Annual Meeting, taking place April 26-29 in Las Vegas. Among the highlights are the 12-month duration of response (DOR) data from the Phase 2b Cohort 2 SunRISe-1 study, evaluating TAR-200—an intravesical gemcitabine releasing system—for patients with Bacillus Calmette-Guérin (BCG)—unresponsive, high-risk non-muscle-invasive bladder can",
      "url": "https://finnhub.io/api/news?id=e353c94c4c3dfe5cdfb5393e8e1eb40bd0bd27efffa1ddbc5cc82573235c19d3"
    }
  },
  {
    "ts": null,
    "headline": "Healthcare ETFs Tug of War: Insurers Tumble, Pharma Surges",
    "summary": "Healthcare ETFs split as insurers stumble and pharma surges -- highlighting the necessity of smart industry picks.",
    "url": "https://finnhub.io/api/news?id=9a20818799793acc9d6b1ad78bb82e46f98a1554205d2ce0043b79d42920e8dd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745238600,
      "headline": "Healthcare ETFs Tug of War: Insurers Tumble, Pharma Surges",
      "id": 134022702,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Healthcare ETFs split as insurers stumble and pharma surges -- highlighting the necessity of smart industry picks.",
      "url": "https://finnhub.io/api/news?id=9a20818799793acc9d6b1ad78bb82e46f98a1554205d2ce0043b79d42920e8dd"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson : unveils highly anticipated and potential practice-changing data in bladder cancer treatment at AUA",
    "summary": "Johnson & Johnson unveils highly anticipated and potential practice-changing data in bladder cancer treatment at AUA TAR-200 monotherapy shows highest complete response with...",
    "url": "https://finnhub.io/api/news?id=775858b9379b36f87888fb46adaafda7e699ac7fef6706e9115a290381f13048",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745228284,
      "headline": "Johnson & Johnson : unveils highly anticipated and potential practice-changing data in bladder cancer treatment at AUA",
      "id": 134022061,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson & Johnson unveils highly anticipated and potential practice-changing data in bladder cancer treatment at AUA TAR-200 monotherapy shows highest complete response with...",
      "url": "https://finnhub.io/api/news?id=775858b9379b36f87888fb46adaafda7e699ac7fef6706e9115a290381f13048"
    }
  }
]